First in the World: Irish-Owned Ethos Engineering Earns Well Performance Rating for Dublin HQ “Living Lab”

Using Data and Occupant Experience to Create Healthier, Safer and More Productive Offices and Workspaces. DUBLIN, Ireland – Ethos, one of EMEA’s leading providers of Data Centre Mechanical and Electrical Design Consultancy, sustainable commercial and smart fit-out buildings, today announced it is the first business in the world to achieve the WELL Performance Rating through… Read More »

CREST launches OWASP Verification Standard (OVS) Program

CREST OVS will provide increased levels of assurance for application security assessments. 4 August 2022: CREST, the international not-for-profit, membership body representing the global cyber security industry, in consultation with the Open Web Application Security Project (OWASP), today announced the OWASP Verification Standard (OVS), a new quality assurance standard for the global application security industry.… Read More »

Odaseva Announces Date for Data Innovation Forum for Enterprise-level Salesforce Architects

Virtual event in October will allow leading Salesforce architects to discuss ideas, opportunities, and strategies to maximize the value of Salesforce data SAN FRANCISCO – JULY 21, 2022 – Odaseva, leading enterprise data platform for Salesforce, has announced the date for its two-day Data Innovation Forum, to be held on October 26-27, 2022. The stakes… Read More »

Rajant And AMERICAN INTERNATIONAL RADIO (A.I.R.) Partnership to Bring Kinetic Mesh Networking to Middle East, Turkey, And Azerbaijan

A.I.R., EMEA’s Largest Two-way Radio Reseller and Rajant Provide a Natural Complement Malvern, PA – July 20, 2022: Rajant Corporation, the pioneer of Kinetic Mesh® wireless networks headquartered in Malvern, Pennsylvania, has entered into a strategic distribution agreement with AMERICAN INTERNATIONAL RADIO (A.I.R.), a leading radio communication solutions and mobility/IT applications provider. This agreement represents… Read More »

How Pfizer Profited From the Pandemic

According to Kaiser Health News (KHN),1 the COVID-19 pandemic has been a real boon to Pfizer. Not only has it yielded “outsize benefits” in terms of profits, but it has also “given the drugmaker unusual weight in determining U.S. health policy.” “Based on internal research, the company’s executives have frequently announced the next stage in… Read More »